Medical Ikkou, Sep-Nov (3Q) Ordinary Profit Decreases by 14%

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

Fri Jan 10, 2025 3:30 pm JST Earnings

3353 Medical Ikkou Group Co.,Ltd 【J-GAAP】

Earnings Report

Medical Ikkou Group Co.,Ltd <3353> [TSE Std] announced its financial results after the market closed on January 10th (15:30). The consolidated ordinary profit for the cumulative third quarter of the fiscal year ending February 2025 (March to November) increased 7.2% from the same period last year, reaching 1.27 billion yen. However, the progress rate toward the full-year plan of 1.8 billion yen was 70.9%, almost the same as the five-year average of 72.8%.

Based on the cumulative third-quarter performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the December to February period (4Q) is expected to decrease 6.6% from the same period last year to 0.52 billion yen.

In the most recent three-month period, from September to November (3Q), the consolidated ordinary profit decreased to 0.42 billion yen, a 14.4% decrease compared to the same period last year. The operating profit margin worsened from 4.2% in the same period last year to 3.0%.

Kabutan News

Actual Results

Accumulated Results 3rd Quarter

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Progress Rate vs. First Half	Announce	Accounting Standards
Mar - Nov, 2022	25,427	705	888	597	159.0	72.4	Jan 10, 2023	J-GAAP
Mar - Nov, 2023	28,769	1,078	1,190	812	216.2	68.0	Jan 10, 2024	J-GAAP
Mar - Nov, 2024	35,090	1,203	1,276	999	265.8	70.9	Jan 10, 2025	J-GAAP
YoY	+22.0%	+11.6%	+7.2%	+23.0%	+22.9%

Current Period Guidance

Second Half Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Sep - Feb, 2023	22,450	956	1,055	595	158.5	25	Apr 5, 2024	J-GAAP
Sep - Feb, 2024 Guidance	23,595	972	947	501	133.2	25	Oct 7, 2024	J-GAAP
YoY	+5.1%	+1.7%	-10.2%	-15.8%	-16.0%

Current Period Guidance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Feb, 2023	33,897	935	1,227	759	202.2	40	Apr 7, 2023	J-GAAP
Feb, 2024	39,900	1,559	1,751	1,039	276.7	45	Apr 5, 2024	J-GAAP
Feb, 2025 Guidance	46,260	1,800	1,800	1,210	321.7	50	Apr 5, 2024	J-GAAP
YoY	+15.9%	+15.5%	+2.8%	+16.5%	+16.2%

Quarterly Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Sep - Nov, 2023	11,319	475	494	368	98.0	4.2	Jan 10, 2024	J-GAAP
Dec - Feb, 2023	11,131	481	561	227	60.5	4.3	Apr 5, 2024	J-GAAP
Mar - May, 2024	11,183	429	430	429	114.2	3.8	Jul 8, 2024	J-GAAP
Jun - Aug, 2024	11,482	399	423	280	74.5	3.5	Oct 7, 2024	J-GAAP
Sep - Nov, 2024	12,425	375	423	290	77.2	3.0	Jan 10, 2025	J-GAAP
YoY	+9.8%	-21.1%	-14.4%	-21.2%	-21.3%